Category: News
2021 Year End FSR Highlights
This year, the Foundation for Sarcoidosis Research (FSR) has made incredible progress towards our mission thanks to your support! There have been significant strides made towards accelerating research initiatives and providing resources to patients around the...
#GivingTuesday – November 30, 2021
#GivingTuesday marks the official start to the charitable giving season! On #GivingTuesday we want to you join us in creating a movement to help stop sarcoidosis. To help celebrate this international day of giving back, we are going to take social media by...
FSR Awarded $600,000 Chan Zuckerberg Initiative: Rare As One Cycle 2 Grant in Diversity, Diagnosis, and Clinical Trials
We are proud to announce that they have been selected as an awardee for the Chan Zuckerberg Initiative (CZI) Rare As One Cycle 2 grant which will provide $600,000 to improve diagnostics and increase research in sarcoidosis. This work is part of CZI’s Rare...
Congratulations to the 2021 FSR Small Research Grant Awardees
FSR is pleased to announce the 2021 Small Research Grant Awardees. As part of our mission, FSR accelerates sarcoidosis research through fellowships, small grants, and large grant programs, and has dedicated over $5M million for worldwide sarcoidosis research since...
Ignore No More: Foundation for Sarcoidosis Research Launches African American Women & Sarcoidosis Campaign
The Foundation for Sarcoidosis Research (FSR) is excited to announce the official launch of the first of its kind African American Women & Sarcoidosis National Campaign (AAWS). African American women experience the highest incidence of sarcoidosis in the US as...
Mary’s Anniversary
Mary McGowan’s Reflections on her First Year Anniversary as FSR’s CEO Over the last year, I learned how resilient the FSR community is, especially during these challenging times of a pandemic. I am so impressed by the passion, dedication and focus...
WHO Air Quality Guidelines Update: Health experts urge nations to implement ambitious air pollution reduction policies
Health experts urge nations to implement ambitious air pollution reduction policies Health experts and patient representative groups have issued a joint statement urging nations to implement ambitious clean air policies without delay in order to protect health. The...
aTyr Pharma Announces Positive Data from Phase 1b/2a Pulmonary Sarcoidosis Clinical Trial
On September 13, 2021, aTyr Pharma announced positive results from their Phase1b/2a clinical trial for ATYR1923 in pulmonary sarcoidosis. FSR is proud to have supported this clinical trial. The trial demonstrated that ATYR1923 was safe and well-tolerated, 33%...